Navigation Links
Mirixa Australia Achieves Six Month Milestones
Date:11/17/2009

RESTON, Va. and SYDNEY, Nov. 17 /PRNewswire/ -- Mirixa Corporation, the leader in pharmacy-based patient care services and the Pharmacy Guild of Australia, the peak body representing owners of pharmacies across Australia, announced today results of the first six months of operating activity of Mirixa Australia.

In less than two full quarters of operation, Mirixa Australia has successfully engaged over 40% of all pharmacies nationwide, enabling the delivery of patient care services via the customized Australian version of the MirixaPro(SM) clinical platform.

Mirixa Australia, a subsidiary of the Pharmacy Guild of Australia, now operates patient medication adherence programs, delivered person-to-person at community pharmacy, for both brand and generic medications. Current Australian programs include GSK's Seretide, Pfizer's Lipitor, and generic simvastatin, pravastatin, omeprazole and sertraline medicines offered by Australia's three largest generic medicine distributors, namely Alphapharm, Apotex and Sigma. Programs generally target those patients whose MedsIndex score falls below 70 - an indicator of sub-optimal adherence. The Pharmacy Guild of Australia created and introduced MedsIndex in 2007, and with the help of the Mirixa U.S. team, integrated this score into programs offered through the MirixaPro clinical platform in Australia.

"We're quite proud of what our Australian pharmacy colleagues have accomplished over a very short span of time," said Rick Solano, President and Chief Executive Officer of Mirixa. "The growth rate achieved by Mirixa Australia and its pharmacy partners is truly impressive. They are well on their way to establishing a national pharmacy network to deliver meaningful patient care services similar to what we've achieved here in the U.S.," added Mr. Solano.

Analysis of data by Mirixa Australia across all programs for one of its pilot network pharmacies reveal
'/>"/>

SOURCE Mirixa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mirixa Corporation Announces MirixaEdge(SM)
2. Mirixa Corporation Announces Key Pharmacy Network Hire
3. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
4. New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers
5. S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis
6. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
7. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
8. New Australian Technology: Detecting Breast Cancer With Hair
9. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
10. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
11. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation ... to support older adults suffering from the severe ... AARP and its members are committed to helping those ... AARP and AARP Foundation will match dollar-for-dollar contributions up ... aid. The matching program will be administered through AARP ...
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion ... today announced that it has received commitments from ... $15 million of the Company,s common stock in ... dedicated health care fund. The Company ... pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, ... the Office of Fair Trading (OFT) approval condition to the ... ViroPharma Incorporated (NASDAQ: VPHM).   As a result ... OFT approval, and Shire expects to complete the tender offer ... subject to the satisfaction of all of the remaining conditions ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... 2011 PDI, Inc. (Nasdaq: PDII ), a ... companies, today announced the extension of a contract sales engagement ... began April 1 and will run for the balance of ... PDI of approximately $23 million. Under the program, ...
... April 4, 2011 VIVUS, Inc. (Nasdaq: VVUS ... the investigational drug QNEXA® for two years showed reductions in ... as improvements in lipid levels following significant reductions in weight ... two years. The data – additional results ...
Cached Medicine Technology:PDI Announces Contract Extension With Revenue Value of Approximately $23 Million 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3
(Date:4/14/2014)... the scientific marvels of the 20th century, is currently ... bacterial infections. But scientists at the University of South ... its combat effectiveness, even against so-called "superbugs." , Bacteria ... penicillin family of drugs since their first wide-scale use ... infection, brought about by the bacterium Staphylococcus aureus ...
(Date:4/14/2014)... information on colorectal cancer is too difficult for most ... risks to and concerns of patients, a study by ... review of a dozen popular websites, most of the ... written beyond the recommended sixth-grade reading level, while content ... well as the barriers to and benefits of screening, ...
(Date:4/14/2014)... SOUTH SAN FRANCISCO, Calif.--True North Therapeutics, Inc., announced ... antibody prevents the destruction of human red blood ... a type of autoimmune hemolytic anemia (AIHA). The ... protease C1s, prevents complement activation induced by cold ... the journal Blood earlier this month. ...
(Date:4/14/2014)... Frank Porter Graham Child Development Institute have released ... program to prepare four-year-olds for success in kindergarten. ... Pre-K show significant gains across all areas of ... even greater rate during their participation in NC ... senior scientist Ellen Peisner-Feinberg, who leads the FPG ...
(Date:4/14/2014)... about health that aren,t based on medical evidence are ... research suggests. , In the Ohio State University study, ... as "irrational health beliefs" on a standard measure of ... a prescribed cardiac rehab program. , Among the ... flu vaccine or believing, based on family history alone, ...
Breaking Medicine News(10 mins):Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3
... Kashmir University Wednesday suspended construction of a guesthouse inside the ... following student protests . ,Vice Chancellor Abdul Wahid ... campus here. ,Hundreds of students had launched an ... chinar trees being felled to make way for the construction. ...
... peoples sleep. Some are light sleepers, whereas others sleep ... their time . ,Such sleeping pattern ... circumstances, habits, and other non-biological factors. But now a ... and assistant director of the Sleep and Performance Research ...
... The international HIV and AIDS charity AVERT is today launching ... end to the 380,000 child AIDS deaths and half ... year. ,At this year's G8 summit in Germany, the ... chance to stop child AIDS deaths by committingspecific funds for ...
... breast Cancer treatment comes in the form of Intraoperative ... radiation during surgery . Thus the patient can avoid ... the Princess Margaret Hospital team combined the expertise of ... and nurses to perform its first procedure. It marked ...
... today seems to be disintegrating at an alarming rate. Studies ... one in ten children now has a mental health disorder ... More than a million children have mental health problems, a ... conduct disorders have become twice as common since the 1930s ...
... The Canadian Food Inspection Agency has issued a warning to ... Alberta, Ontario, Quebec and Nova Scotia as it could ... the product has been done by Les Aliments G. Dion. ... the market. ,Salmonella contaminated food does not appear ...
Cached Medicine News:Health News:Individual Differences in Sleep Structure are Biologically Determined 2Health News:AIDS Charity AVERT Launches Stop AIDS in Children Campaign 2Health News:Intraoperative Radiation Therapy a New Step in Breast Cancer Treatment 2Health News:Mental Health of Children on the Decline 2
... insulin pen with a memory. HumaPen MEMOIR records the ... (including priming doses). You can see exactly when and ... you simply "dial" your dose by turning the dose ... initial set-up. If you dial too many units, you ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: